Triumvira Immunologicsincis A Clinical Stage Immuno Oncology Company Dedicated To Developing Innovative T Cell Therapies For Cancer Treatmentthe Company Leverages Its Deep Understanding Of T Cell Biology To Create Both Autologous And Allogeneic T Cell Therapeuticstriumvira S Tact Cell Antigen Couplertechnology Enables T Cells To Effectively Target And Destroy Tumor Cellsaiming To Provide Safer And More Effective Treatments For A Variety Of Cancersincluding Solid Tumors And Hematological Cancers Founded By Jonathan Bramsonphdand Christopher Helsenphdand Led By Ceo Paul Lammersmdmsctriumvira Is Building A Robust Pipeline Of Tac T Cell Therapiesthe Company Utilizes Advanced Manufacturing Technologies To Ensure High Product Quality And Is Supported By A Strong Intellectual Property Portfoliotriumvira S Mission Is To Improve Patientslives By Developing Therapies That Empower The Immune System To Combat Serious Diseases
No conferences found for this company.
| Company Name | Triumvira Immunologics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
